CD274 and neoplasm: Nanoparticles, nano-immunotherapy, herbal medicines, and agents that overcome hypoxia-mediated immunosuppression are all potential approaches to augment PD-L1 expression on tumor cells to promote the PD-L1/PD-1 interaction.